SCHEMBL5907288

SCHEMBL5907288

OCc1cnn(-c2ccc(-c3ccccc3)nc2)c1-c1ccccc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.36
PTGS1 P23219 1/20 0.36
DHODH Q02127 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
CHRNB2 P17787 2/20 0.35
CHRNA7 P36544 2/20 0.35
CHRNA4 P43681 2/20 0.35
HSP90AA1 P07900 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
S1PR1 P21453 2/20 0.35
GRM2 Q14416 1/20 0.34
LDHA P00338 1/20 0.33
KCNN4 O15554 1/20 0.33
CYP11B1 P15538 3/20 0.33
CYP11B2 P19099 2/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5907234 0.83 PTGS1 (0.38) PTGS2PTGS1DHODHNPC1RAB9A
SCHEMBL5907378 0.83 ALDH1A1 (0.42) PTGS2CHRNB2CHRNA7CHRNA4
SCHEMBL5907410 0.83 PDCD1 (0.38) PTGS2PTGS1NPC1RAB9ACHRNB2
SCHEMBL27633455 0.82 S1PR1 (0.39) PTGS2PTGS1DHODHNPC1RAB9A
SCHEMBL5907275 0.81 CYP2A13 (0.44) SMN1; SMN2ALOX5APFEN1
SCHEMBL5907291 0.81 MAP4K1 (0.41) CHRNB2CHRNA7CHRNA4
SCHEMBL5907388 0.81 SSTR5 (0.37) CHRNB2CHRNA7CHRNA4ALOX5APFEN1
SCHEMBL5907287 0.81 SSTR5 (0.41) MEN1KMT2A
SCHEMBL5907312 0.81 SSTR5 (0.41) PTGS2PTGS1CHRNB2CHRNA4MEN1
SCHEMBL5907324 0.81 CD274 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264419-A1 Substituted pyrazoles MERCK PATENT GMBH (DE) 2006-11-23 US disclosed
CN-1768051-A Substituted pyrazoles MERCK PATENT GMBH (DE) 2006-05-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264419-A1 Substituted pyrazoles HTR3A, HTR1A, HTR1D PTGS2 2319/4885PTGS1 887/4885DHODH 3663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.